Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wadi Hazou"'
Weaker SARS-CoV-2 vaccine responses in nonalcoholic fatty liver disease with advanced liver fibrosis
Autor:
David Hakimian, Johnny Amer, Alaa Jammal, Asher Shafrir, Yael Milgrom, Mohammad Masarowah, Wadi Hazou, Yuval Ishay, Ashraf Imam, Adi Francis, Abed Khalaileh, Rifaat Safadi
Publikováno v:
Vaccine: X, Vol 15, Iss , Pp 100359- (2023)
Background: SARS-CoV-2 vaccine responses that could harbor potential risks to chronic liver diseased patients. Aims: To assess immune response following Pfizer's SARS-CoV-2 vaccine in patients with different liver fibrosis severities of nonalcoholic
Externí odkaz:
https://doaj.org/article/af4b55d4ed4142b8ae2d7851c624af9a
Autor:
Asher Shafrir, Johnny Amer, David Hakimian, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Ashraf Imam, Abed Khalaileh, Rifaat Safadi
Publikováno v:
Hepatology Communications, Vol 6, Iss 6, Pp 1278-1288 (2022)
The Pfizer‐BioNTech coronavirus disease 2019 (COVID‐19) vaccine has been offered to nonallergic ≥16‐year‐old Israeli adults since December 19, 2020. Data regarding factors associated with vaccine ineffectiveness are limited. The aim of this
Externí odkaz:
https://doaj.org/article/cd9a690df7864ba9997fbbefd41c1d36
Autor:
Abed Khalaileh, Ashraf Imam, Alaa Jammal, David Hakimian, Johnny Amer, Asher Shafrir, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Majd Khader, Rifaat Safadi
Publikováno v:
Hepatology Communications, Vol 7, Iss 2, Pp e0025-e0025 (2023)
Background and Aims:. We retrospectively assessed the clinical Pfizer’s mRNA SARS-CoV-2 BNT162b2 vaccination outcomes and the serologic impact on liver transplant (LT) recipients. Patients and Methods:. One hundred and sixty-seven LT cases followed
Externí odkaz:
https://doaj.org/article/020387f3a17a42739f439edb3b27ebdf
Autor:
Saleh Daher, Namma Lev Cohen, Muhammad Massarwa, Mahmud Mahamid, Mira Nasser, Wadi Hazou, Rani Oren, Rifaat Safadi, Tawfik Khoury
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0207479 (2018)
Background and aimThe progression of non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH) is believed to be the driver for future development of fibrosis and cirrhosis. Nevertheless, there remains a clear deficit in non-i
Externí odkaz:
https://doaj.org/article/c63d5016c3c840d4aca6d22b1c05052e
Autor:
Avital Bareket-Samish, Michael H. Silverman, Pnina Fishman, Assaf Issachar, Adi Francis, Naama Lev-Cohain, Yael Milgrom, Zivit Harpaz, Muhammad Massarwa, Inbal Itzhak, Wadi Hazou, Marius Braun, Rifaat Safadi, David Hakimian, Motti Farbstein
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:1405-1415
Background Namodenoson, an A3 adenosine receptor (A3AR) agonist, improved liver function/pathology in non-alcoholic steatohepatitis (NASH) preclinical models. Aim To evaluate the efficacy and safety of namodenoson for the treatment of non-alcoholic f
Autor:
Asher Shafrir, Johnny Amer, David Hakimian, Yael Milgrom, Muhammad Massarwa, Wadi Hazou, Ashraf Imam, Abed Khalaileh, Rifaat Safadi
Publikováno v:
Hepatology communications. 6(6)
The Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine has been offered to nonallergic ≥16-year-old Israeli adults since December 19, 2020. Data regarding factors associated with vaccine ineffectiveness are limited. The aim of this study i
Autor:
Rifaat Safadi, Marius Braun, Adi Francis, Yael Milgrom, Muhammad Massarwa, David Hakimian, Wadi Hazou, Assaf Issachar, Zivit Harpaz, Motti Farbstein, Inbal Itzhak, Naama Lev‐Cohain, Avital Bareket‐Samish, Michael H. Silverman, Pnina Fishman
Publikováno v:
Alimentary Pharmacology & Therapeutics. 55:485-486
Autor:
Amir Mari, Anas Kadah, Amir Shahin, Wadi Hazou, Wisam Sbeit, Tawfik Khoury, Lior H Katz, Asher Shafrir, Itai Kalisky
Publikováno v:
Minerva medica. 112(4)
Background Inflammatory bowel disease (IBD) is a set of chronic inflammatory diseases associated with significant morbidity and high hospitalization rate. IBD patients are particularly prone to re-hospitalization resulting in high medical cost and mo
Autor:
Harold Jacob, Muhammad Massarwa, Julia Epstein, Ariel A. Benson, Wadi Hazou, Eran Israeli, Tawfik Khoury, Rifaat Safadi, Saleh Daher
Publikováno v:
Hepatology Communications
There are limited efficacious therapeutic options for management of gastric variceal bleeding. Treatment modalities include transjugular intrahepatic portosystemic shunt, surgical shunts, and endoscopic interventions, including the recent advancement
Autor:
Lior H Katz, Mahmud Mahamid, Anas Kadah, Wisam Sbeit, Tawfik Khoury, Amir Mari, Wadi Hazou, Itai Kalisky, Asher Shafrir
Publikováno v:
Minerva medica. 111(6)
BACKGROUND Inflammatory bowel disease (IBD) is a set of chronic inflammatory diseases associated with significant morbidity. Generally, IBD patients have twice the risk of venous thromboembolism (VTE) compared to healthy controls. VTE can occur both,